H Syndrome

Watchlist
Retrieved
2021-01-18
Source
Trials
Drugs

H syndrome, also known as Histiocytosis-lymphadenopathy plus syndrome or PHID, is a rare genetic condition caused by mutations in the SLC29A3 gene which encode the human equilibrative nucleoside transporter (hENT3) protein.

It is also known as Faisalabad histocytosis, familial Rosai-Dorfman disease, sinus histocytosis with massive lymphadenopathy and pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome.

Presentation

This syndrome has a number of different clinical features many of which start with the letter 'H' giving rise to the name of the syndrome. These features include

  • Hyperpigmentation
  • Hypertrichosis
  • Hepatosplenomegaly
  • Hearing loss
  • Heart anomalies
  • Hypogonadism
  • Low height (short stature)
  • Hyperglycemia/diabetes mellitus
  • Hallux valgus/flexion contractures

Exophthalmos, malabsorption and renal anomalies have also been reported.

Genetics

The SLC29A3 gene is located on the long arm of chromosome 10 (10q22).

The causative gene was identified in 2010.

Pathogenesis

This is not understood at present.

Management

There is no curative treatment for this condition at present. Management is directed to the clinical features.

History

This condition was first described in 1998.